Preeclampsia and later cardiovascular disease - What do national guidelines recommend?

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Disease Research
• Public Health

Background:

• Preeclampsia is a significant risk factor for long-term hypertension and cardiovascular disease (CVD) in women.
• Current clinical guidelines for managing post-preeclamptic patients show considerable international variation.
• Discrepancies exist in the definition of preeclampsia and recommended screening protocols for CVD risk reduction.

Purpose of the Study:

• To compare and analyze the latest clinical recommendations from eight national associations on preventing hypertension and CVD in post-preeclamptic women.
• To identify variations in screening strategies and definitions of preeclampsia impacting CVD prevention.

Main Methods:

• Systematic review and comparative analysis of clinical practice guidelines.
• Focused on recommendations from national associations of gynecologists and obstetricians.
• Examined definitions of preeclampsia and strategies for post-preeclamptic CVD risk screening.

Main Results:

• Substantial international variation exists in definitions of preeclampsia.
• Significant differences observed in recommendations for screening frequency, methods, and target populations for post-preeclamptic CVD risk.
• Lack of standardized, cost-efficient follow-up strategies complicates comparative analysis.

Conclusions:

• Divergent preeclampsia definitions hinder the comparison of CVD prevention strategies.
• Variations in clinical recommendations underscore the need for further research.
• Optimizing post-preeclampsia CVD prevention requires evidence-based, standardized follow-up protocols.